⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9951460 | 0.92 | — | — | |
| SCHEMBL27955288 | 0.89 | TSHR (0.52) | — | |
| SCHEMBL28251564 | 0.89 | TSHR (0.52) | — | |
| SCHEMBL50289 | 0.88 | — | — | |
| SCHEMBL120965 | 0.86 | SMN1; SMN2 (0.58) | — | |
| SCHEMBL735058 | 0.84 | — | — | |
| SCHEMBL10835848 | 0.83 | TSHR (0.60) | — | |
| SCHEMBL11529305 | 0.83 | TSHR (0.60) | — | |
| SCHEMBL10412274 | 0.83 | TSHR (0.60) | — | |
| SCHEMBL27311624 | 0.83 | TSHR (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 423 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230054591-A1 | AGROCHEMICAL GEL COMPOSITIONS | MONSANTO TECHNOLOGY LLC | 2023-02-23 | — | — | US | claimed |
| US-10765668-B2 | Oral tablet composition comprising dexlansoprazole, oral tablet comprising the same and method for manufacturing the same | LOTTE FINE CHEMICAL CO., LTD. (KR) | 2020-09-08 | — | — | US | claimed |
| US-20200254041-A1 | RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS | RECEPTOR HOLDINGS, INC. (US) | 2020-08-13 | — | — | US | claimed |
| EP-3672610-A1 | RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS | Receptor Holdings, Inc. (US) | 2020-07-01 | — | — | EP | claimed |
| CN-111225678-A | Plant and synthetic cannabinoid formulations with rapid onset and prolonged action | 受体控股公司 | 2020-06-02 | — | — | CN | claimed |
| EP-3646855-A2 | ORAL SOLID PREPARATION COMPOSITION COMPRISING PROTON PUMP INHIBITOR, ORAL SOLID PREPARATION COMPRISING SAME, AND PREPARATION METHOD THEREFOR | LOTTE Fine Chemical Co., Ltd. (KR) | 2020-05-06 | — | — | EP | claimed |
| CN-110785164-A | Solid preparation composition for oral administration comprising proton pump inhibitor, solid preparation for oral administration comprising the same, and method for producing the same | 乐天精密化学株式会社 | 2020-02-11 | — | — | CN | claimed |
| EP-3545951-A1 | ORAL TABLET COMPOSITION COMPRISING DEXLANSOPRAZOLE, ORAL TABLET COMPRISING SAME AND METHOD FOR MANUFACTURING SAME | LOTTE Fine Chemical Co., Ltd. (KR) | 2019-10-02 | — | — | EP | claimed |
| US-20190275023-A1 | ORAL TABLET COMPOSITION COMPRISING DEXLANSOPRAZOLE, ORAL TABLET COMPRISING THE SAME AND METHOD FOR MANUFACTURING THE SAME | LOTTE FINE CHEMICAL CO., LTD. (KR) | 2019-09-12 | — | — | US | claimed |
| WO-2019071213-A1 | RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS | RECEPTOR LIFE SCIENCES, INC. (US) | 2019-04-11 | — | — | WO | claimed |
| EP-2007378-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | Amorepacific Corporation (KR) | 2008-12-31 | — | — | EP | claimed |
| WO-2007123338-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | AMOREPACIFIC CORPORATION (KR) | 2007-11-01 | — | — | WO | claimed |
| CN-1988889-A | Sustained-release preparations containing topiramate and the producing method thereof | AMOREPACIFIC CORP (KR) | 2007-06-27 | — | — | CN | claimed |
| CN-1926181-A | Porous body and method for producing same | UNILEVER PLC (NL) | 2007-03-07 | — | — | CN | claimed |
| CN-1914263-A | Porous materials and method of production thereof | UNILEVER NV (NL) | 2007-02-14 | — | — | CN | claimed |
| US-20060222713-A1 | Extended release pharmaceutical composition of phenytoin sodium | RANBAXY LABORATORIES LIMITED (IN) | 2006-10-05 | — | — | US | claimed |
| CN-1832730-A | Controlled release formulations | ALPHARMA INC (US) | 2006-09-13 | — | — | CN | claimed |
| CN-1741790-A | Sustained-release preparations and method for producing the same | AMOREPACIFIC CORP (KR) | 2006-03-01 | — | — | CN | claimed |
| WO-2004058152-A2 | AN EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF PHENYTOIN SODIUM | RANBAXY PHARMACEUTICALS INC. (US) | 2004-07-15 | — | — | WO | claimed |
| WO-2004054550-A1 | AN EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF PHENYTOIN SODIUM | RANBAXY LABORATORIES LIMITED (IN) | 2004-07-01 | — | — | WO | claimed |